Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone dose comparison after total knee arthroplasty
IRCT20180422039382N6Phase 3Not yet recruiting
- Sponsor
- Babol University of Medical Sciences
- Start
- Nov 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone in postoperative pain (3 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: pain severity. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
prednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20180422039382N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180422039382N6.